Characterization of the genomic landscape of HIV-associated lymphoma reveals heterogeneity across histological subtypes.

Autor: Hybel TE; Department of Hematology, Aarhus University Hospital.; Department of Clinical Medicine, Aarhus University., Sørensen EF; Department of Hematology, Aarhus University Hospital., Enemark MH; Department of Hematology, Aarhus University Hospital.; Department of Clinical Medicine, Aarhus University., Hemmingsen JK; Department of Hematology, Aarhus University Hospital., Simonsen AT; Department of Pathology, Aarhus University Hospital, Aarhus., Lauridsen KL; Department of Pathology, Aarhus University Hospital, Aarhus., Møller MB; Department of Pathology., Pedersen C; Department of Infectious Diseases, Odense University Hospital, Odense., Pedersen G; Department of Infectious Diseases, Aalborg University Hospital, Aalborg., Obel N; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen., Larsen CS; Department of Infectious Diseases., d'Amore F; Department of Hematology, Aarhus University Hospital., Hamilton-Dutoit S; Department of Pathology, Aarhus University Hospital, Aarhus., Stougaard M; Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark., Vase MØ; Department of Hematology, Aarhus University Hospital., Ludvigsen M; Department of Hematology, Aarhus University Hospital.; Department of Clinical Medicine, Aarhus University.

Publikováno v: AIDS (London, England) [AIDS] 2024 Nov 15; Vol. 38 (14), pp. 1897-1906. Date of Electronic Publication: 2024 Aug 22.

Imaging Flow Cytometry and Convolutional Neural Network-Based Classification Enable Discrimination of Hematopoietic and Leukemic Stem Cells in Acute Myeloid Leukemia.

Autor: Hybel TE; Department of Hematology, Aarhus University Hospital, 8200 Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark., Jensen SH; Department of Hematology, Aarhus University Hospital, 8200 Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark., Rodrigues MA; Amnis Flow Cytometry, Cytek Biosciences, Seattle, WA 98119, USA., Hybel TE; Department of Hematology, Aarhus University Hospital, 8200 Aarhus N, Denmark., Pedersen MN; Department of Hematology, Aarhus University Hospital, 8200 Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark., Qvick SH; Department of Hematology, Aarhus University Hospital, 8200 Aarhus N, Denmark., Enemark MH; Department of Hematology, Aarhus University Hospital, 8200 Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark., Bill M; Department of Hematology, Aarhus University Hospital, 8200 Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark., Rosenberg CA; Department of Hematology, Aarhus University Hospital, 8200 Aarhus N, Denmark., Ludvigsen M; Department of Hematology, Aarhus University Hospital, 8200 Aarhus N, Denmark.; Department of Clinical Medicine, Aarhus University, 8200 Aarhus N, Denmark.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2024 Jun 12; Vol. 25 (12). Date of Electronic Publication: 2024 Jun 12.

Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma.

Autor: Ludvigsen M; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark. majlud@rm.dk.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. majlud@rm.dk., Campbell AJ; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Enemark MB; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Hybel TE; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Karjalainen-Lindsberg ML; Department of Pathology, Helsinki University Hospital, Helsinki, Finland., Beiske K; Department of Pathology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway., Bjerre M; Medical/Steno Aarhus Research Laboratory, Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Pedersen LM; Zealand University Hospital, Roskilde, Denmark., Holte H; Department of Oncology, Oslo University Hospital, Oslo, Norway.; KG Jebsen Center for B-Cell Malignancies, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Norwegian Cancer Genomics Consortium, Oslo, Norway., Leppä S; Research Program Unit, Applied Tumor Genomics, Faculty of Medicine, University of Helsinki, Helsinki, Finland.; Department of Oncology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland., Jørgensen JM; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Honoré B; Department of Biomedicine, Aarhus University, Aarhus, Denmark. bh@biomed.au.dk.

Publikováno v: Blood cancer journal [Blood Cancer J] 2023 Oct 26; Vol. 13 (1), pp. 161. Date of Electronic Publication: 2023 Oct 26.

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus.

Autor: Hybel TE; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Vase MØ; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Lauridsen KL; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Enemark MB; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark., Møller MB; Department of Pathology, Odense University Hospital, Odense, Denmark., Pedersen C; Department of Infectious Diseases, Odense University Hospital, Odense, Denmark., Pedersen G; Department of Infectious Diseases, Aalborg University Hospital, Aalborg, Denmark., Hamilton-Dutoit S; Department of Pathology, Aarhus University Hospital, Aarhus, Denmark., Obel N; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark., Schade Larsen C; Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark., d'Amore F; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark., Ludvigsen M; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2022 Jun; Vol. 63 (6), pp. 1479-1483. Date of Electronic Publication: 2022 Jan 12.

Three-Dimensional Growth of Prostate Cancer Cells Exposed to Simulated Microgravity.

Autor: Dietrichs D; Department of Microgravity and Translational Regenerative Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany., Grimm D; Department of Microgravity and Translational Regenerative Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.; Research Group 'Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen' (MARS), Otto von Guericke University Magdeburg, Magdeburg, Germany.; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Sahana J; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Melnik D; Department of Microgravity and Translational Regenerative Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany., Corydon TJ; Department of Biomedicine, Aarhus University, Aarhus, Denmark.; Department of Ophthalmology, Aarhus University Hospital, Aarhus, Denmark., Wehland M; Department of Microgravity and Translational Regenerative Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.; Research Group 'Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen' (MARS), Otto von Guericke University Magdeburg, Magdeburg, Germany., Krüger M; Department of Microgravity and Translational Regenerative Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.; Research Group 'Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen' (MARS), Otto von Guericke University Magdeburg, Magdeburg, Germany., Vermeesen R; Radiobiology Unit, SCK CEN, Belgian Nuclear Research Centre, Mol, Belgium., Baselet B; Radiobiology Unit, SCK CEN, Belgian Nuclear Research Centre, Mol, Belgium., Baatout S; Radiobiology Unit, SCK CEN, Belgian Nuclear Research Centre, Mol, Belgium.; Department of Molecular Biotechnology, Ghent University, Ghent, Belgium., Hybel TE; Department of Biomedicine, Aarhus University, Aarhus, Denmark., Kahlert S; Institute of Anatomy, Otto von Guericke University Magdeburg, Magdeburg, Germany., Schulz H; Department of Microgravity and Translational Regenerative Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.; Research Group 'Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen' (MARS), Otto von Guericke University Magdeburg, Magdeburg, Germany., Infanger M; Department of Microgravity and Translational Regenerative Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.; Research Group 'Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen' (MARS), Otto von Guericke University Magdeburg, Magdeburg, Germany., Kopp S; Department of Microgravity and Translational Regenerative Medicine, Otto von Guericke University Magdeburg, Magdeburg, Germany.; Research Group 'Magdeburger Arbeitsgemeinschaft für Forschung unter Raumfahrt- und Schwerelosigkeitsbedingungen' (MARS), Otto von Guericke University Magdeburg, Magdeburg, Germany.

Publikováno v: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2022 Feb 17; Vol. 10, pp. 841017. Date of Electronic Publication: 2022 Feb 17 (Print Publication: 2022).